Japan Diet OKs Bill for Emergency Approval of Drugs

Politics Society Health

Tokyo, May 13 (Jiji Press)--The Diet, Japan's parliament, on Friday enacted a bill to create a system granting emergency regulatory approval to vaccines, drugs and other medical goods in urgent situations such as when an infectious disease is spreading.

The bill to amend the pharmaceuticals and medical devices law was approved unanimously at a plenary meeting of the House of Councillors, the upper chamber of the Diet, on the day. The amendment cleared the House of Representatives, the lower chamber, earlier.

Under the system, regulatory approval would be given to drugs and vaccines even before the completion of clinical trials if their safety is confirmed and their effectiveness can be estimated.

The establishment of the system comes after Japan lagged behind the United States and European countries in putting COVID-19 vaccines to practical use.

Vaccines that are being distributed overseas and estimated to be effective, for example, can be given emergency approval without clinical trials in Japan, enabling quicker distribution than under the current special pharmaceutical approval system.

[Copyright The Jiji Press, Ltd.]

Jiji Press